Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...
The guidelines now recommend that doctors consider prescribing these drugs, including those sold under the brand names ...
With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...
Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.
Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.
No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug ...